Quadrant Biosciences Wins New York Technology Award

gmcnaught, Author at Clarifi

Can Identifying Autism Earlier Cost Less in the Long-Term?

Currently 1 in 59 children in the United States are diagnosed with ASD (autism spectrum disorder). This condition is a neurodevelopmental disorder that is characterized by difficulties in behavior, social interaction, communication, and sensory sensitivities. Now, current research indicates that early intervention leads to better outcomes for the child. However, diagnosis can take more than


New Research Suggests That Bacteria Within a Child’s Mouth Could Help Identify Autism

New research has recently emerged that “changes in the bacteria within a child’s mouth may provide biomarkers for identifying autism.”[1] Previous research has established the presence of a disrupted gut-brain signaling in children with autism spectrum disorder (ASD). [2] Most of that research focused on examining the lower digestive system. New research has now demonstrated


Supporting our community

Supporting Our Community This past November, Quadrant Biosciences had the opportunity to visit the AAP (American Academy of Pediatrics) Conference in Orlando, FL. We were so excited to unveil our autism saliva test to thousands of pediatricians from across the world, that we brought some extra goodies, too… But the biggest hit were our custom


Meet our team!

Meet our team! Lindsay Lee Vice President of Operations and Commercialization Lindsay joined the QB team in 2018 and has been running the ship ever since. Well, at least the shipment part of things. As VP of Operations and Commercialization, Lindsay is responsible for leading the Clarifi project commercialization process to bring our product to